YARROW BIOSCIENCE, INC. Payments to Acquire Investments
YARROW BIOSCIENCE, INC. (YARW) reported Payments to Acquire Investments of $0 for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2020-08-06
- YARROW BIOSCIENCE, INC. payments to acquire investments for the quarter ending 2019-12-31 was $5.05M, a 69.84% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire investments for the quarter ending 2019-09-30 was $62.30M, a 134.37% increase year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire investments for the quarter ending 2019-06-30 was $8.05M, a 24.03% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire investments for the quarter ending 2019-03-31 was $8.00M, a 89.01% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire investments for fiscal 2019 was $83.40M, a 34.18% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. payments to acquire investments for fiscal 2018 was $126.70M, a 97.51% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. payments to acquire investments for fiscal 2017 was $64.15M, a 15.98% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. payments to acquire investments for fiscal 2016 was $55.31M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 3 month as first filed | Payments to Acquire Investments 6 month | Payments to Acquire Investments 6 month as first filed | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|---|---|
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | |||||
| 2019-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $67.35M derived: sum of 2 quarters · filed 2020-03-03 | $75.40M derived: sum of 3 quarters · filed 2020-08-06 | $83.40M 10-K · filed 2020-03-03 | ||
| 2019-09-30 | $62.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $70.35M derived: sum of 2 quarters · filed 2020-08-06 | $78.35M 10-Q · filed 2019-10-31 | $95.09M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-06-30 | $8.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $16.05M 10-Q · filed 2020-08-06 | $34.94M 10-Q · filed 2019-08-01 | $32.80M derived: sum of 3 quarters · filed 2020-08-06 | $59.38M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $8.00M 10-Q · filed 2020-05-11 | $21.40M 10-Q · filed 2019-05-02 | $24.75M derived: sum of 2 quarters · filed 2020-05-11 | $51.33M derived: sum of 3 quarters · filed 2020-05-11 | $61.92M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $16.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $43.33M derived: sum of 2 quarters · filed 2020-03-03 | $53.92M derived: sum of 3 quarters · filed 2020-03-03 | $126.70M 10-K · filed 2020-03-03 | ||
| 2018-09-30 | $26.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $37.17M derived: sum of 2 quarters · filed 2019-10-31 | $109.95M 10-Q · filed 2019-10-31 | $114.93M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-06-30 | $10.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $83.37M 10-Q · filed 2019-08-01 | $88.35M derived: sum of 3 quarters · filed 2020-03-03 | $138.29M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-03-31 | $72.78M 10-Q · filed 2019-05-02 | $77.75M derived: sum of 2 quarters · filed 2020-03-03 | $127.70M derived: sum of 3 quarters · filed 2020-03-03 | $128.70M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $54.92M derived: sum of 2 quarters · filed 2020-03-03 | $55.92M derived: sum of 3 quarters · filed 2020-03-03 | $64.15M 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $49.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $50.94M derived: sum of 2 quarters · filed 2018-11-07 | $59.17M 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $997.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $9.22M 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | $8.23M 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | $55.31M 10-K · filed 2019-02-28 | |||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |